Taking the next step in the management of relapsed or refractory follicular lymphoma

Taking the next step in the management of relapsed or refractory follicular lymphoma

In this online, self-learning activity: Follicular lymphoma (FL) is the second most common lymphoma in the United States and in Europe. FL accounts for around 35% of all non-Hodgkin lymphomas and five percent of all hematologic malignancies. It has an incidence of 3.18 cases per 100,000 people, and while FL usually remains indolent for several years, one in ten patients has disease that is resistant to initial chemoimmunotherapy. Moreover, a fifth of patients relapse within the first two years of initial treatment, and most eventually relapse at some point during their lives.

  • Provider:ScientiaCME
  • Activity Link: https://www.scientiacme.org/cme-527-111-0-1-99-follicular-lymphoma-fl-cme
  • Start Date: 2024-06-28 05:00:00
  • End Date: 2024-06-28 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Beigene - Amount: 20425.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Hematology, Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.